190
Participants
Start Date
October 27, 2020
Primary Completion Date
December 24, 2027
Study Completion Date
December 24, 2029
Cretostimogene Grenadenorepvec
Engineered Oncolytic Adenovirus
n-dodecyl-B-D-maltoside
Transduction-enhancing agent.
Keelung Chang Gung Memorial Hospital, Keelung
National Cancer Center, Goyang-si
Keystone Urology Specialists, Lancaster
University of Pennsylvania, Perelman School of Medicine, Philadelphia
MedStar Hospital, Washington D.C.
Chesapeake Urology, Severna Park
Duke University, Durham
Carolina Urologic Research Center, Myrtle Beach
Emory University, Atlanta
Mayo Clinic - Jacksonville, Jacksonville
Moffit Cancer Center, Tampa
Urology Associates- Nashville, Nashville
Vanderbilt University Medical Center, Nashville
Conrad Pearson Clinic, Germantown
China Medical University Hospital, Taichung
University of Toledo, Toledo
Urology of Indiana, Greenwood
Pusan National University Hospital, Busan
Pusan National University Yangsan Hospital, Gyeongsang
Mayo Rochester, Rochester
Chonnam National University Hwasun Hospital, Jeongnam
Mercy Medical Center, St Louis
Washington University, St Louis
Specialty Clinical Research of St. Louis, St Louis
University of Kansas, Kansas City
Wichita Urology, Wichita
Southern Urology, Lafayette
Arkansas Urology, Little Rock
Houston Metro Urology, Houston
Urology San Antonio, PA, San Antonio
University of Colorado, Aurora
Urology Associates, Lone Tree
Colorado Clinical Research, Lakewood
Mayo Clinic Cancer Center, Phoenix
Arizona Institute of Urology, Tucson
University of California - Irvine, Irvine
Spokane Urology, Spokane
Brigham and Women's Hospital, Boston
Barwon Health, University Hospital Geelong, Geelong
Royal Melbourne Hospital, Melbourne
Wollongong Private Hospital, Wollongong
National Cancer Center Hospital East, Chiba
Nagoya University Hospital, Fujita
Hirosaki University Hospital, Hashimoto
Chugoku Rosai Hospital, Hiroshima
Shinshu University Hospital, Ishizuka
University of Tsukuba Hospital, Kandori
Nara Medical University Hospital, Kashihara
The Jikei University Kashiwa Hospital, Kashiwa
St. Marianna University Hospital, Kikuchi
National Hospital Organization Kyoto Medical Center, Kyoto
Kagawa Rosai Hospital, Marugame
Keio University Hospital, Matsumoto
Okayama University Hospital, Okayama
Osaka City University Hospital, Osaka
Osaka Medical and Pharmaceutical University Hospital, Osaka
Kitsato University Hospital, Sagamihara
Saitama City Hospital, Saitama
Sapporo Medical University Hospital, Sapporo
Shizuoka General Hospital, Shizuoka
Keio University Hospital, Tokyo
Toyoma University Hospital, Toyoma
Ehime University Hospital, Tōon
Wakayama Medical University Hospital, Wakayama
National Hospital Organization Yokohama Medical Center, Yokohama
Korea University Anam Hospital, Seoul
Severance Hospital, Seoul
The Catholic University of Korea, Seoul
Keelung Chang Gung Memorial Hospital, Keelung
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Seoul National University Hospital, Seoul
Lead Sponsor
CG Oncology, Inc.
INDUSTRY